Your prediction
Protalix Biotherapeutics Inc. Stock
Heavy losses for Protalix Biotherapeutics Inc. today as the stock fell by -€0.070 (-3.350%).
Our community identified positive and negative aspects for Protalix Biotherapeutics Inc. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Protalix Biotherapeutics Inc. stock. On the other hand our users think that "Growth compared to competition" could be a problem in the future.
Pros and Cons of Protalix Biotherapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Protalix Biotherapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | -3.350% | -0.713% | 4.239% | 58.333% | 36.601% | 43.544% | 48.227% |
| Compugen Ltd. | -2.860% | -3.398% | 5.851% | 51.216% | 51.216% | 113.978% | -63.486% |
| Chromadex Corp | -1.400% | -7.947% | -6.081% | -66.303% | -49.455% | 85.333% | -64.129% |
| Intellia Therapeutics Inc | 2.090% | -4.970% | -34.610% | -15.436% | 22.470% | -75.117% | -91.687% |
